Home » Newsletters » BioWorld Science

BioWorld Science

May 15, 2020

View Archived Issues

Liver-specific pre-eclampsia treatment is maternal-specific

Novadip reports interim data from phase I/II bone non-union study of NVD-003

Advaxis reports positive preliminary data from ongoing phase I/II study of ADXS-503 in NSCLC

Abivax receives clearance to initiate phase IIb/III study of ABX-464 COVID-19 patients

FDA approves IND application for SMP-100 as treatment of IBS

Krystal Biotech announces positive interim data from phase I/II study of KB-105

Kaleido initiates developmental program of KB-109 in mild to moderate COVID-19

SHR-170008 immunotherapy demonstrates antitumor efficacy in vivo

Pharmacodynamic and safety data presented for emixustat

Researchers identify AMRC-835 for MBL-positive Gram-negative bacterial infections

Phase II/III data support potential of rAAV2-ND4 gene therapy in patients with LHON

Daiichi Sankyo, Sanford Burnham Prebys patent AP-TNAP inhibitors

Taiho Pharmaceutical discloses mutant GTPase KRAS inhibitors

New factor XIa and/or kallikrein B inhibitors identified at Merck & Co.

Bristol-Myers Squibb discovers Toll-like receptor antagonists

New kappa opioid receptor agonists synthesized at Nippon Chemiphar

Doubling down on edits keeps type 1 diabetes in check

EGFR identified as a target in some retinoblastoma tumors

MCo-PG1 shows good efficacy in Pseudomonas aeruginosa-driven sepsis model

European Commission approves Adcetris for previously untreated sALCL

Enzychem cleared to begin Korean phase II study with EC-18 to prevent ARDS in COVID-19

Danish study to evaluate iloprost in COVID-19 patients with ARDS

FDA accepts IND for iNKT therapy agenT-797 for cancer

Lyfaquin approved in India for hypovolemic shock